Entheon Biomedical Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
ENBI.X
- Investments
-
3
- Share Price
-
$0.04
- (As of Friday Closing)
Entheon Biomedical General Information
Description
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.
Contact Information
Website
www.entheonbiomedical.comCorporate Office
- 999 West Broadway Street
- Suite 720
- Vancouver, British Columbia V5Z 1K5
- Canada
Corporate Office
- 999 West Broadway Street
- Suite 720
- Vancouver, British Columbia V5Z 1K5
- Canada
Entheon Biomedical Timeline
Entheon Biomedical Stock Performance
As of 13-Nov-2026, Entheon Biomedical’s stock price is $0.04. Its current market cap is $486K with 13.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.04 | $0.04 | $0.03 - $0.09 | $486K | 13.9M | 29.4K |
Entheon Biomedical Financials Summary
As of 31-May-2026, Entheon Biomedical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-May-2026 | FY 2025 30-Nov-2025 | FY 2024 30-Nov-2024 | FY 2023 30-Nov-2023 |
|---|---|---|---|---|
| EV | 765 | 722 | 154 | |
| Revenue | 0 | 0 | 0 | 185 |
| EBITDA | 31 | (238) | (244) | (227) |
| Net Income | 31 | (231) | (233) | (222) |
| Total Assets | 378 | 253 | 132 | 295 |
| Total Debt | 0 | 0 | 0 |
Entheon Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Entheon Biomedical Signals
Entheon Biomedical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Entheon Biomedical Acquisitions (3)
Entheon Biomedical’s most recent deal was a Merger/Acquisition with Lobo Genetics for . The deal was made on 29-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Lobo Genetics | 29-Jul-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| HaluGen Life Sciences | 14-Jan-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| M.P.V. Explorations | 05-Nov-2020 | Merger/Acquisition | Multi-line Mining |
Entheon Biomedical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Entheon Biomedical Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| HaluGen Life Sciences | Mississauga, Canada | 2020 | |
| Lobo Genetics | Mississauga, Canada | 2018 |
Entheon Biomedical FAQs
-
When was Entheon Biomedical founded?
Entheon Biomedical was founded in 2010.
-
Where is Entheon Biomedical headquartered?
Entheon Biomedical is headquartered in Vancouver, Canada.
-
What is the size of Entheon Biomedical?
Entheon Biomedical has 4 total employees.
-
What industry is Entheon Biomedical in?
Entheon Biomedical’s primary industry is Drug Discovery.
-
Is Entheon Biomedical a private or public company?
Entheon Biomedical is a Public company.
-
What is Entheon Biomedical’s stock symbol?
The ticker symbol for Entheon Biomedical is ENBI.X.
-
What is the current stock price of Entheon Biomedical?
As of 13-Nov-2026 the stock price of Entheon Biomedical is $0.04.
-
What is the current market cap of Entheon Biomedical?
The current market capitalization of Entheon Biomedical is $486K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process